Zenotech Laboratories Ltd
Zenotech Laboratories Ltd Live Price Chart
Performance
| Previous Close | ₹ 44.26 |
| High | ₹ 44.79 |
| Volume | 6503 |
| 52W Range | ₹ 33.55 - ₹ 56.99 |
| Open | ₹ 44.58 |
| Low | ₹ 44.22 |
| Market Cap | ₹ 279.95 Cr |
Zenotech Laboratories Ltd Technicals
| 20 Day | ₹ 45.444 |
| 50 Day | ₹ 45.364 |
| 100 Day | ₹ 45.377 |
| 200 Day | ₹ 47.037 |
| 20 Day | ₹ 45.802 |
| 50 Day | ₹ 45.454 |
| 100 Day | ₹ 45.210 |
| 200 Day | ₹ 45.140 |
Zenotech Laboratories Ltd Fundamentals
| ROCE | 4.358 |
| P/E Ratio | -107.950 |
| P/B Ratio | 2.840 |
| Industry P/E | 2.840 |
| Debt to Equity | 50.284 |
| ROE | -1.127 |
| EPS | -0.410 |
| Dividend Yield | 0.000 |
| Book Value | 15.586 |
| Face Value | 10.000 |
Zenotech Laboratories Ltd Financials
| Particulars | Y202603 | Y202503 | Y202403 | Y202303 | Y202203 |
|---|---|---|---|---|---|
| Total Revenue | 45.9226 | 44.5957 | 41.8372 | 43.508 | 37.1944 |
| Total Expenses | 41.5385 | 35.827 | 30.6958 | 29.0057 | 27.2931 |
| Profit After Tax | -1.0721 | 5.6129 | 8.2987 | 11.5853 | 22.1759 |
Zenotech Laboratories Ltd Shareholding Pattern
| Promoter Holdings | 68.842 % |
| FIIs | 0.000 % |
| DIIs | 0.007 % |
| MutualFund | 0.000 % |
| Retail | 22.808 % |
| Others - | 8.343 % |
About Zenotech Laboratories Ltd
Zenotech Laboratories Limited was initially established as Sunline Technologies Limited in June, 1989 and changed to the present name w.e.f. August 9, 2004. Company is a loan licensing company catering exclusively to Sun Pharmaceutical Industries Limited, Promoter & holding company and they are specialized contract manufacturing services /processing in parenteral depot formulations, ophthalmic, oncology oral & injectables and general injectables. Company's injectables product portfolio primarily serves niche therapy areas like oncology and anesthesiology. During financial year 2004-05, the Hon'ble High Court of Andhra Pradesh sanctioned the Scheme of Amalgamation with M/s. Zenotech Technologies Limited with effect from November 1st , 2003. The Company had issued 91,82,500 equity shares to erstwhile shareholders of M/s. Zenotech Laboratories Pvt. Ltd. M/s, Credence Pharmaceuticals Limited and M/s, Hemarus Healthcare Private Limited were merged with the Company, on May 2, 2006 through Scheme of Amalgamation, effective from October 1, 2005. 15 generic chemical oncology products were launched by the Company in India. Besides, the Company launched its anesthesia range of products during 2006. In 2005-06, M/s, Credence Pharmaceuticals Limited and M/s, Hemarus Healthcare Private Limited got merged with the Company and the Scheme of Amalgamation became effective from October 1, 2005. Consequent to the consummation of the merger of Ranbaxy Laboratories Limited into SPIL ...
Similar Stocks
| Ambalal Sarabhai Enterprises Ltd Pharmaceuticals | ₹ 38.75 +0.12 (+0.31%) |
| Amrutanjan Health Care Ltd Pharmaceuticals | ₹ 483.10 -6.6 (-1.35%) |
| Astrazeneca Pharma India Ltd Pharmaceuticals | ₹ 6,870.65 +177.3 (+2.65%) |
| Bliss GVS Pharma Ltd Pharmaceuticals | ₹ 660.00 -26.35 (-3.84%) |
| Abbott India Ltd Pharmaceuticals | ₹ 26,120.75 -22.6 (-0.09%) |
| Cipla Ltd Pharmaceuticals | ₹ 1,360.00 -1 (-0.07%) |
FAQs on Zenotech Laboratories Ltd
1. Can I buy Zenotech Laboratories Ltd from PL Capital? ›
2. Does Zenotech Laboratories Ltd pay dividends? ›
3. What is the current share price of Zenotech Laboratories Ltd ? ›
4. What is the 52-week high and low of Zenotech Laboratories Ltd ? ›
5. What is the market capitalisation of Zenotech Laboratories Ltd? ›
6. What is the current P/E ratio of Zenotech Laboratories Ltd? ›
7. What is the current P/B ratio of Zenotech Laboratories Ltd? ›
8. What is the shareholding pattern of Zenotech Laboratories Ltd? ›
9. What is the 1-year return of Zenotech Laboratories Ltd? ›
Start SIP in Zenotech Laboratories Ltd
Invest systematically in stocks with the
PL Capital app
Are you a new user? Open your account
